Cortot AB, Madroszyk-Flandin A, Giroux Leprieur E, Molinier O, et al. First-line Afatinib plus Cetuximab for EGFR-mutant Non-small-cell Lung Cancer: Results from the Randomized Phase 2 IFCT-1503 ACE-Lung Study. Clin Cancer Res 2021 May 24. pii: 1078-0432.CCR-20-4604.
PMID: 34031056